Every successful product on a retail shelf started as a sentence on a napkin. PMG's R&D team turns that sentence into a stable, compliant, manufacturable, market-ready formulation — backed by our team’s decades of experience across health, wellness, personal care, beauty, and nutraceuticals.
Most first-time inventors think "R&D" means a chemist mixing ingredients in a beaker. Real product R&D is the work that separates a product that sells from a product that gets stuck in a warehouse: market viability analysis, formulation against your specific claims, ingredient sourcing within your cost target, stability prediction, regulatory compliance design, and patent-readiness.
Get R&D right and the rest of the value chain runs smoothly. Get it wrong — pick the wrong actives, miss a regulatory requirement, design a formula that won't survive a hot truck in July — and every downstream stage suffers.
Our chemists are paired with channel and regulatory specialists from the first meeting. The formulation isn't just 'does it work' — it's 'does it work at this cost, in this packaging, with this shelf life, for this retailer's compliance standards.'
We maintain a proprietary library of proven, FDA (Food and Drug Administration)-compliant, retail-tested base formulations. You can launch on a stock formula in as little as 60 days, then move to custom in year two once you have sales data. Most first-time brands save 6–12 months and significant cost by starting here.
If your roadmap includes Latin America, we formulate for it from the start — ingredient lists that comply with COFEPRIS (Federal Commission for the Protection against Sanitary Risk – Mexico), ANVISA (National Health Surveillance Agency – Brazil), and EU cosmetic standards built in, not bolted on later.
A phase-by-phase breakdown of R&D, ingredients, production, packaging, and compliance costs.
Read the article →Why minimums exist, what they cost below volume, and how to plan a first run you can sell through.
Read the article →Your product's success is largely determined by decisions made in R&D. This is not the stage to cut corners or rush.
